Press release
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea
Download Free Sample of Report- https://www.globalinsightservices.com/request-sample/GIS31258
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe.
Dysmenorrhea is thought to be caused by the release of prostaglandins, hormones that are involved in the regulation of pain and inflammation.
Primary Dysmenorrhea is diagnosed by symptoms like lower pelvic or abdominal pain and is usually associated with the onset of menstrual flow and lasts 8-72 hours. Secondary Dysmenorrhea is diagnosed with symptoms like a change in the time of pain onset during the menstrual cycle or in the intensity of pain along with pelvic abnormality on physical examination.
There are several treatments available for dysmenorrhea. These include over-the-counter pain relievers such as ibuprofen or naproxen, birth control pills, and, in some cases, surgery.
Request For Customization - https://www.globalinsightservices.com/request-customization/GIS31258
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Dysmenorrhea treatment such as FSN-013, Linzagolix, Relugolix and others. Key players involved in the development of therapies to treat Dysmenorrhea are Fuji Pharma Japan Inc, Latitude Pharmaceuticals Inc, Myovant Sciences GmbH, ObsEva SA, PNB Vesper Life Sciences and others. Three drugs are under late-stage Phase III clinical trials and one drug are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.
Report Highlights
Global Insight Service's, Dysmenorrhea - Drug Pipeline Landscape, 2023 report provides an overview of the Dysmenorrhea pipeline drugs. This report covers detailed insights on Dysmenorrhea drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Dysmenorrhea pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
For In-Depth Competitive Analysis, Purchase this Report- https://www.globalinsightservices.com/inquiry-before-buying/GIS3125
Reasons to Buy
Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dysmenorrhea - Drug Pipeline Landscape, 2022 here
News-ID: 2900914 • Views: …
More Releases from Global Insight Services
Radar Sensor Market Set to Expand from $14.7 Billion in 2024 to $37.9 Billion by …
The radar sensor market is rapidly gaining attention as industries embrace advanced sensing technologies for safety, automation, and efficiency. Radar sensors are designed to detect, track, and analyze objects with high precision, making them indispensable across automotive, aerospace, defense, and consumer electronics. With the growing integration of autonomous vehicles, smart cities, and security systems, the radar sensor market is positioned as a cornerstone of next-generation innovation. Its ability to perform…
Well Intervention Market Set to Expand from $9.2 Billion in 2024 to $16.5 Billio …
The Well Intervention Market plays a pivotal role in the global energy sector, providing services and technologies that enhance the performance, longevity, and safety of oil and gas wells. Well intervention operations involve diagnostics, maintenance, stimulation, and repair activities, all aimed at improving productivity and extending the life of existing wells. With rising global energy demand and the growing focus on efficiency, this market has become a cornerstone for sustainable…
Log Management Market Is Anticipated To Expand From $3.1 Billion In 2024 To $10. …
Market Overview
The Log Management Market has become a cornerstone of modern IT and cybersecurity strategies. With enterprises generating vast amounts of log data from applications, networks, and cloud platforms, managing this information has never been more critical. Log management solutions are designed to collect, monitor, store, and analyze these logs, helping businesses improve security, comply with regulations, and optimize performance. As organizations face rising cyber threats and increasingly complex IT…
Occupational Health Market Is Anticipated To Expand From $4.5 Billion In 2024 To …
Market Overview
The Occupational Health Market is gaining strong momentum as organizations increasingly recognize the importance of workplace safety, regulatory compliance, and employee well-being. Estimated at $4.5 billion in 2024, the market is projected to nearly double and reach $8.9 billion by 2034, reflecting a steady CAGR of 7.1%. This sector encompasses a wide range of services, solutions, and technologies, including preventive health assessments, ergonomic solutions, compliance training, wellness programs, and…
More Releases for Dysmenorrhea
Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:
The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of…
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Survey and 2027 Foresight Report
Dysmenorrhea Treatment: Market Overview
Globally, more than 50% of post pubescent menstruating women are affected by dysmenorrhea, with 10–12% of them having severe dysmenorrhea with incapacitation for 1–3 days each month. Because young women constitute a significant percentage of the adult work force in the US, nearby 600 million working hours or 2 billion dollars are lost annually because of incapacitating dysmenorrhea if adequate relief is not provided. Women who continue…
